Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development
Technology
E-013-2018
Patent ID
E-013-2018-0-US-03
Country
US
Application Type
ORD
Patent Status
Issued
Patent Number
10501539
Publication Number
Application Number
16/132,064
IC
NCI
Date Filed
Date Issued